Feed STJO
Summary
83 / 100 · Bulios Score
Valuation 100Growth -Profitability 99Quality 29Debt 100Stability 100
What speaks for it
- Out of every 100 USD of revenue, 23 USD is left as net profit.
- It holds more cash than debt: $282.6K against $110.4K.
- You pay 0.6 USD for 1 USD of yearly profit, little for its sector.
What to watch
- It earns only 5.4 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapMedical - Devices industry median
P/E today 0.6
Today you pay 0.6 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Revenue (USD)
2022202320242025
Diluted EPS (USD)
2022202320242025
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 20 USD
- Sales and administration 55 USD
- Taxes and other 1.1 USD
- Net profit 23 USD
Net profit, industry median (Medical - Devices) 6.9 USD
Out of every 100 USD of revenue, 23 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $282.6K
Debt $110.4K
Free cash flow over 12 months $344.6K
It could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.